Pharmaceutical Production Inside Merck KGaA Health Care Laboratory

Russian cyrillic script sits on bottles of Nasavin nasal spray as they pass through a labeling machine inside Merck KGaA's pharmaceutical laboratories at the company's headquarters in Darmstadt, Germany, on Thursday, Nov. 3, 2016. Merck and Idemitsu Kosan Co Ltd. today signed an agreement to allow each party to use the other's organic light-emitting diode (OLED) material-related patents in certain areas. Photographer: Martin Leissl/Bloomberg via Getty Images
Russian cyrillic script sits on bottles of Nasavin nasal spray as they pass through a labeling machine inside Merck KGaA's pharmaceutical laboratories at the company's headquarters in Darmstadt, Germany, on Thursday, Nov. 3, 2016. Merck and Idemitsu Kosan Co Ltd. today signed an agreement to allow each party to use the other's organic light-emitting diode (OLED) material-related patents in certain areas. Photographer: Martin Leissl/Bloomberg via Getty Images
Pharmaceutical Production Inside Merck KGaA Health Care Laboratory
COMPRAR LICENCIA
¿Cómo puedo usar esta imagen?
AR$ 329.200,00
ARS

DETALLES

Restricciones:
Póngase en contacto con su oficina local para conocer todos los usos con fines comerciales o promocionales.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial n.º:
621622120
Colección:
Bloomberg
Fecha de creación:
03 de noviembre de 2016
Fecha de subida:
Tipo de licencia:
Con derechos gestionados
Inf. de autorización:
No se cuenta con autorizaciones. Más información
Fuente:
Bloomberg
Nombre del objeto:
GERMANY MERCK
Tamaño máx. archivo:
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 3 MB